ZA200202293B - Orally distintegrating composition comprising mirtazapine. - Google Patents

Orally distintegrating composition comprising mirtazapine. Download PDF

Info

Publication number: ZA200202293B
Authority: ZA; South Africa
Prior art keywords: mirtazapine; dosage unit; orally; tablets; unit according
Prior art date: 1999-10-13

Application number

ZA200202293A

Other languages

English (en)

Inventor

Henrik De Nijs

Original Assignee

Akzo Nobel Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-13

Filing date

2002-03-20

Publication date

2003-06-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8240737&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200202293(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-03-20 Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv

2003-06-20 Publication of ZA200202293B publication Critical patent/ZA200202293B/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Zoology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

ZA200202293A 1999-10-13 2002-03-20 Orally distintegrating composition comprising mirtazapine. ZA200202293B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP99203338		1999-10-13

Publications (1)

Publication Number	Publication Date
ZA200202293B true ZA200202293B (en)	2003-06-20

Family

ID=8240737

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200202293A ZA200202293B (en)	1999-10-13	2002-03-20	Orally distintegrating composition comprising mirtazapine.

Country Status (28)

Country	Link
EP (1)	EP1223914B1 (pt)
JP (1)	JP5561885B2 (pt)
KR (1)	KR100708560B1 (pt)
CN (1)	CN1173701C (pt)
AR (1)	AR026010A1 (pt)
AT (1)	ATE274899T1 (pt)
AU (1)	AU780379B2 (pt)
BR (1)	BR0014593A (pt)
CA (1)	CA2386547C (pt)
CO (1)	CO5251412A1 (pt)
CZ (1)	CZ20021315A3 (pt)
DE (2)	DE60013466T2 (pt)
ES (1)	ES2194618T3 (pt)
HK (1)	HK1046641B (pt)
HU (1)	HUP0203148A3 (pt)
IL (2)	IL148777A0 (pt)
MX (1)	MXPA02003519A (pt)
NO (1)	NO20021730L (pt)
NZ (1)	NZ518165A (pt)
PE (1)	PE20010699A1 (pt)
PL (1)	PL200858B1 (pt)
PT (1)	PT1223914E (pt)
RU (1)	RU2261098C2 (pt)
SK (1)	SK6452002A3 (pt)
TR (1)	TR200200978T2 (pt)
TW (1)	TWI256309B (pt)
WO (1)	WO2001026621A2 (pt)
ZA (1)	ZA200202293B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070298107A1 (en) *	2003-11-25	2007-12-27	Aurobindo Pharma Ltd.	Pharmaceutical Compositions of Mirtazapine
DE102004034043A1 (de) *	2004-07-13	2006-02-09	Krka Tovarna Zdravil, D.D.	Feste pharmazeutische Zusammensetzung, die Mirtazapin enthält
JP2009528289A (ja) *	2006-02-27	2009-08-06	ミシャロウ、アレクサンダー	対抗適応を誘発することにより神経伝達物質系を調節する方法
CN101129341B (zh) *	2006-08-22	2011-06-01	上海医药工业研究院	口内崩解组合物及其制备方法
EP2377522B1 (en)	2010-04-15	2013-01-16	Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi	Orally disintegrating tablet formulations of mirtazapine and process for preparing the same
CN102993208B (zh)	2011-11-22	2017-01-18	北京哈三联科技股份有限公司	去甲肾上腺素和选择性五羟色胺受体阻断剂及其应用
ES2821773T3 (es) *	2012-03-02	2021-04-27	Rhodes Pharmaceuticals Lp	Formulaciones de liberación inmediata resistentes a la manipulación
CN104095824B (zh) *	2013-04-09	2016-08-31	上海信谊万象药业股份有限公司	一种米氮平缓释片及其制备方法
PT3261645T (pt)	2015-02-27	2021-06-17	Dechra Ltd	Estimulação do apetite, gestão da perda de peso, e tratamento da anorexia em cães e gatos
JP6601844B2 (ja) *	2016-12-05	2019-11-06	共和薬品工業株式会社	光安定性に優れたミルタザピン含有医薬製剤
CN111714463B (zh) *	2020-08-14	2022-06-17	华农（肇庆）生物产业技术研究院有限公司	米氮平口服剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8724763D0 (en) *	1987-10-22	1987-11-25	Aps Research Ltd	Sustained-release formulations
US5178878A (en) *	1989-10-02	1993-01-12	Cima Labs, Inc.	Effervescent dosage form with microparticles
EP0494972B1 (en) *	1989-10-02	1996-11-27	Cima Labs, Inc.	Effervescent dosage form and method of administering same
IE63986B1 (en) *	1989-12-30	1995-06-28	Akzo Nv	Pharmaceutical preparation for oral administration in fluid form
JPH0436252A (ja) *	1990-05-30	1992-02-06	Nippon Alkyl Alum Kk	光学活性アルキニルアルコールの製造方法
JP3168695B2 (ja) *	1991-06-14	2001-05-21	三菱化学株式会社	ショ糖脂肪酸エステルの置換度の低下方法
US5464632C1 (en) *	1991-07-22	2001-02-20	Prographarm Lab	Rapidly disintegratable multiparticular tablet
JPH05163137A (ja) *	1991-12-12	1993-06-29	Shin Etsu Chem Co Ltd	有核顆粒
CA2128820A1 (en) *	1993-07-27	1995-01-28	Walter G. Gowan, Jr.	Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
JPH0737473A (ja) *	1993-07-27	1995-02-07	Murata Mfg Co Ltd	圧力スイッチ
JPH10139659A (ja) *	1996-09-10	1998-05-26	Freunt Ind Co Ltd	球形粒子群、その製造方法及びそれを用いた球形粒子製剤
JP3870470B2 (ja) *	1997-02-07	2007-01-17	大正製薬株式会社	マルチプルユニットタイプ徐放性錠剤

2000
- 2000-09-19 TW TW089119264A patent/TWI256309B/zh not_active IP Right Cessation
- 2000-10-09 MX MXPA02003519A patent/MXPA02003519A/es unknown
- 2000-10-09 TR TR2002/00978T patent/TR200200978T2/xx unknown
- 2000-10-09 RU RU2002112238/15A patent/RU2261098C2/ru active
- 2000-10-09 IL IL14877700A patent/IL148777A0/xx unknown
- 2000-10-09 HU HU0203148A patent/HUP0203148A3/hu unknown
- 2000-10-09 NZ NZ518165A patent/NZ518165A/en not_active IP Right Cessation
- 2000-10-09 AU AU10232/01A patent/AU780379B2/en not_active Expired
- 2000-10-09 WO PCT/EP2000/009863 patent/WO2001026621A2/en active IP Right Grant
- 2000-10-09 DE DE60013466T patent/DE60013466T2/de not_active Expired - Lifetime
- 2000-10-09 BR BR0014593-9A patent/BR0014593A/pt not_active Application Discontinuation
- 2000-10-09 DE DE1223914T patent/DE1223914T1/de active Pending
- 2000-10-09 JP JP2001529412A patent/JP5561885B2/ja not_active Expired - Lifetime
- 2000-10-09 CN CNB008142041A patent/CN1173701C/zh not_active Expired - Lifetime
- 2000-10-09 ES ES00971346T patent/ES2194618T3/es not_active Expired - Lifetime
- 2000-10-09 SK SK645-2002A patent/SK6452002A3/sk not_active Application Discontinuation
- 2000-10-09 CA CA2386547A patent/CA2386547C/en not_active Expired - Fee Related
- 2000-10-09 EP EP00971346A patent/EP1223914B1/en not_active Revoked
- 2000-10-09 PL PL354584A patent/PL200858B1/pl unknown
- 2000-10-09 AT AT00971346T patent/ATE274899T1/de active
- 2000-10-09 CZ CZ20021315A patent/CZ20021315A3/cs unknown
- 2000-10-09 PT PT00971346T patent/PT1223914E/pt unknown
- 2000-10-09 KR KR1020027004668A patent/KR100708560B1/ko not_active Expired - Lifetime
- 2000-10-11 AR ARP000105347A patent/AR026010A1/es not_active Application Discontinuation
- 2000-10-12 CO CO00077918A patent/CO5251412A1/es active IP Right Grant
- 2000-10-13 PE PE2000001100A patent/PE20010699A1/es not_active IP Right Cessation
2002
- 2002-03-20 ZA ZA200202293A patent/ZA200202293B/en unknown
- 2002-03-20 IL IL148777A patent/IL148777A/en not_active IP Right Cessation
- 2002-04-12 NO NO20021730A patent/NO20021730L/no not_active Application Discontinuation
- 2002-11-13 HK HK02108207.0A patent/HK1046641B/zh not_active IP Right Cessation

Also Published As

Publication number	Publication date
CN1173701C (zh)	2004-11-03
CO5251412A1 (es)	2003-02-28
DE60013466T2 (de)	2005-01-20
RU2002112238A (ru)	2004-01-10
TR200200978T2 (tr)	2002-09-23
DE60013466D1 (de)	2004-10-07
IL148777A (en)	2013-10-31
HUP0203148A2 (hu)	2003-01-28
AU780379B2 (en)	2005-03-17
EP1223914A2 (en)	2002-07-24
PL200858B1 (pl)	2009-02-27
TWI256309B (en)	2006-06-11
ES2194618T1 (es)	2003-12-01
PT1223914E (pt)	2004-11-30
AR026010A1 (es)	2002-12-26
IL148777A0 (en)	2002-09-12
PL354584A1 (en)	2004-01-26
NO20021730L (no)	2002-05-30
HUP0203148A3 (en)	2004-06-28
SK6452002A3 (en)	2002-09-10
CZ20021315A3 (cs)	2002-07-17
ATE274899T1 (de)	2004-09-15
WO2001026621A2 (en)	2001-04-19
ES2194618T3 (es)	2005-04-01
DE1223914T1 (de)	2003-09-18
NZ518165A (en)	2004-03-26
WO2001026621A3 (en)	2001-10-11
KR100708560B1 (ko)	2007-04-19
AU1023201A (en)	2001-04-23
CA2386547A1 (en)	2001-04-19
BR0014593A (pt)	2002-06-11
PE20010699A1 (es)	2001-07-06
NO20021730D0 (no)	2002-04-12
JP2003511403A (ja)	2003-03-25
JP5561885B2 (ja)	2014-07-30
CA2386547C (en)	2010-06-08
EP1223914B1 (en)	2004-09-01
RU2261098C2 (ru)	2005-09-27
CN1378452A (zh)	2002-11-06
HK1046641A1 (en)	2003-01-24
HK1046641B (zh)	2005-04-08
MXPA02003519A (es)	2002-08-20
KR20020038946A (ko)	2002-05-24

Publication	Publication Date	Title
KR101020809B1 (ko)	2011-03-09	펙소페나딘을 함유하는 구강 분산성 정제
US8513439B2 (en)	2013-08-20	Antidepressant oral pharmaceutical compositions
US6245353B1 (en)	2001-06-12	Solid, rapidly disintegrating cetirizine formulations
US20080176955A1 (en)	2008-07-24	Combined administration of benzonatate and guaifenesin
US20040247677A1 (en)	2004-12-09	Multilayer orodispersible tablet
US8455667B2 (en)	2013-06-04	Duloxetine compositions in the form of a powder for suspension in a liquid
US20070036861A1 (en)	2007-02-15	Orally-dispersible multilayer tablet
US20030158265A1 (en)	2003-08-21	Orally administrable pharmaceutical formulation comprising pseudoephedrine hydrochloride and process for preparing the same
EP1223914B1 (en)	2004-09-01	Orally distintegrating composition comprising mirtazapine
CY1653A (en)	1993-05-14	Pharmaceutical compositions with analgesic properties and the preparation and use thereof
ZA200600159B (en)	2007-03-28	Novel solid pharmaceutical composition comprising amisulpride
AU2003224419A1 (en)	2003-09-09	Orally administrable pharmaceutical formulation
JP2004269513A (ja)	2004-09-30	固形製剤
NZ207768A (en)	1987-02-20	Sustained release tablets comprising dipyridamole
CZ79593A3 (en)	1994-01-19	Antitussive preparation
US6926906B2 (en)	2005-08-09	Orally administrable pharmaceutical formulation
US20240082176A1 (en)	2024-03-14	Dropropizine in combination with ambroxol in the dosage form of syrup and tablets